Lunai Bioworks Inc. Debt Conversion, Original Debt, Amount
Lunai Bioworks Inc. (LNAI) reported Debt Conversion, Original Debt, Amount of $900.00 thousand for the 9-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2025-05-15
- 2025-03-31: Debt Conversion, Original Debt, Amount 9 month $900.00K.
- 2024-12-03: Debt Conversion, Original Debt, Amount 1 month $490.00K.
| Period end | Debt Conversion, Original Debt, Amount 1 month | Debt Conversion, Original Debt, Amount 9 month |
|---|---|---|
| 2025-03-31 | $900.00K 10-Q · filed 2025-05-15 | |
| 2024-12-03 | $490.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |